Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Sanara MedTech (SMTI) Return on Assets (2016 - 2025)

Historic Return on Assets for Sanara MedTech (SMTI) over the last 13 years, with Q3 2025 value amounting to 0.51%.

  • Sanara MedTech's Return on Assets fell 4100.0% to 0.51% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.51%, marking a year-over-year decrease of 4100.0%. This contributed to the annual value of 0.12% for FY2024, which is 600.0% down from last year.
  • Latest data reveals that Sanara MedTech reported Return on Assets of 0.51% as of Q3 2025, which was down 4100.0% from 0.15% recorded in Q2 2025.
  • Sanara MedTech's 5-year Return on Assets high stood at 0.06% for Q4 2023, and its period low was 0.51% during Q3 2025.
  • Moreover, its 5-year median value for Return on Assets was 0.13% (2023), whereas its average is 0.16%.
  • Per our database at Business Quant, Sanara MedTech's Return on Assets skyrocketed by 4400bps in 2021 and then crashed by -4100bps in 2025.
  • Sanara MedTech's Return on Assets (Quarter) stood at 0.21% in 2021, then surged by 39bps to 0.13% in 2022, then surged by 52bps to 0.06% in 2023, then tumbled by -183bps to 0.17% in 2024, then tumbled by -201bps to 0.51% in 2025.
  • Its Return on Assets stands at 0.51% for Q3 2025, versus 0.15% for Q2 2025 and 0.18% for Q1 2025.